Novartis

Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines.Bloomberg | Bloomberg | Getty ImagesNovartis has completed the spinoff of its generics and biosimilars…

Exton, Pennsylvania, July 28, 2023 (GLOBE NEWSWIRE) -- For many who have been following the retina market, the news about the emerging safety signal associated with Apellis’ Syfovre in geographic atrophy (GA) feels very similar to the…

Exton, Pennsylvania, July 27, 2023 (GLOBE NEWSWIRE) -- While the approvals of GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have provided rheumatologists and nephrologists with additional options to treat lupus…

New York, USA, July 27, 2023 (GLOBE NEWSWIRE) -- Non-small Cell Lung Cancer Market is Projected to Boost by 2032, Predicts DelveInsight | Key Companies Working in Space - AstraZeneca, BMS, AbbVie, Roche, Merck, Novartis, Pfizer, Takeda,…

New York, USA, July 25, 2023 (GLOBE NEWSWIRE) -- Psoriasis Market to Register Immense Growth by 2032, Predicts DelveInsight | Key Companies Working in Space - Biohaven, Bristol-Myers Squibb, UCB Pharma, Janssen, Novartis, Pfizer,…

Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines.Bloomberg | Bloomberg | Getty ImagesNovartis shares jumped on Tuesday after the Swiss drugmaker raised…

Newark, New Castle, USA, June 21, 2023 (GLOBE NEWSWIRE) -- In accordance with the most recent analysis by Growth Plus Reports, the global market for naloxone was estimated to be worth US$ 1.15 billion in 2022 and expected a revenue CAGR…

Newark, New Castle, USA, June 13, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global glaucoma treatment market was conducted by Growth Plus Reports in 2022 and is valued at US$ 5.89 billion. The market is expected to hit a…

New Year, USA, June 06, 2023 (GLOBE NEWSWIRE) -- Myelodysplastic Syndrome Market to Register Stunning Growth, Estimates DelveInsight | Key Players in the Market - AbbVie, Gilead Sciences, Novartis, AstraZeneca, Sanofi, Incyte, Celgene,…

<!-- Name:DistributionId Value:8829874 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True --> <!-- Name:IcbCode Value: -->…